MRVI
Maravai LifeSciences Holdings Inc
Price:  
2.24 
USD
Volume:  
4,730,761.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MRVI WACC - Weighted Average Cost of Capital

The WACC of Maravai LifeSciences Holdings Inc (MRVI) is 7.9%.

The Cost of Equity of Maravai LifeSciences Holdings Inc (MRVI) is 10.90%.
The Cost of Debt of Maravai LifeSciences Holdings Inc (MRVI) is 5.30%.

Range Selected
Cost of equity 9.20% - 12.60% 10.90%
Tax rate 11.40% - 11.70% 11.55%
Cost of debt 4.50% - 6.10% 5.30%
WACC 6.7% - 9.2% 7.9%
WACC

MRVI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.15 1.38
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.20% 12.60%
Tax rate 11.40% 11.70%
Debt/Equity ratio 0.9 0.9
Cost of debt 4.50% 6.10%
After-tax WACC 6.7% 9.2%
Selected WACC 7.9%